Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Inflammation, Voiding and Benign Prostatic Hyperplasia Progression.

Lloyd GL, Ricke WA, McVary KT.

J Urol. 2019 May;201(5):868-870. doi: 10.1097/JU.0000000000000049. No abstract available.

PMID:
30694937
2.

Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.

Nickel JC, Roehrborn CG, Castro-Santamaria R, Freedland SJ, Moreira DM.

J Urol. 2016 Nov;196(5):1493-1498. doi: 10.1016/j.juro.2016.06.090. Epub 2016 Jul 1.

PMID:
27378134
3.

Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.

Inamura S, Shinagawa T, Hoshino H, Sakai Y, Imamura Y, Yokoyama O, Kobayashi M.

Prostate. 2017 May;77(7):794-802. doi: 10.1002/pros.23319. Epub 2017 Feb 9.

PMID:
28181681
4.

Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.

Inamura S, Ito H, Shinagawa T, Tsutsumiuchi M, Taga M, Kobayashi M, Yokoyama O.

Prostate. 2018 Jul;78(10):743-752. doi: 10.1002/pros.23518. Epub 2018 Apr 2.

PMID:
29608020
5.

Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.

Hu J, Zhang L, Zou L, Hu M, Fan J, Cai Y, Xu G, Fang J, Ding Q, Jiang H.

Int J Urol. 2015 Dec;22(12):1138-42. doi: 10.1111/iju.12914. Epub 2015 Aug 27.

6.

Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.

Carnevale FC, da Motta-Leal-Filho JM, Antunes AA, Baroni RH, Marcelino AS, Cerri LM, Yoshinaga EM, Cerri GG, Srougi M.

J Vasc Interv Radiol. 2013 Apr;24(4):535-42. doi: 10.1016/j.jvir.2012.12.019. Epub 2013 Feb 19.

PMID:
23434084
7.

The relationship between histological prostatitis and lower urinary tract symptoms and sexual function.

Kumsar S, Kose O, Aydemir H, Halis F, Gokce A, Adsan O, Akkaya ZK.

Int Braz J Urol. 2016 May-Jun;42(3):540-5. doi: 10.1590/S1677-5538.IBJU.2015.0254.

8.

Prostatic infarction/infection in acute urinary retention secondary to benign prostatic hyperplasia.

Anjum I, Ahmed M, Azzopardi A, Mufti GR.

J Urol. 1998 Sep;160(3 Pt 1):792-3.

PMID:
9720549
9.

Use of Structural Equation Modeling to Demonstrate the Differential Impact of Storage and Voiding Lower Urinary Tract Symptoms on Symptom Bother and Quality of Life during Treatment for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.

McVary KT, Peterson A, Donatucci CF, Baygani S, Henneges C, Clouth J, Wong D, Oelke M.

J Urol. 2016 Sep;196(3):824-30. doi: 10.1016/j.juro.2016.04.062. Epub 2016 Apr 19.

PMID:
27105760
10.

Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.

van Vuuren SP, Heyns CF, Zarrabi AD.

BJU Int. 2012 Apr;109(8):1194-7. doi: 10.1111/j.1464-410X.2011.10527.x. Epub 2011 Aug 18.

11.

Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, and Urinary Retention.

Alawamlh OAH, Goueli R, Lee RK.

Med Clin North Am. 2018 Mar;102(2):301-311. doi: 10.1016/j.mcna.2017.10.005. Epub 2017 Dec 21. Review.

PMID:
29406059
12.

The pathophysiology of lower urinary tract symptoms in the ageing male population.

Lepor H.

Br J Urol. 1998 Mar;81 Suppl 1:29-33. Review. No abstract available.

PMID:
9589015
13.

Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?

Yamanishi T, Kaga K, Fuse M, Shibata C, Kamai T, Uchiyama T.

Int J Urol. 2015 Dec;22(12):1143-8. doi: 10.1111/iju.12915. Epub 2015 Aug 27.

14.

Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study.

Toren P, Margel D, Kulkarni G, Finelli A, Zlotta A, Fleshner N.

BMJ. 2013 Apr 15;346:f2109. doi: 10.1136/bmj.f2109.

15.

The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).

Gandaglia G, Briganti A, Gontero P, Mondaini N, Novara G, Salonia A, Sciarra A, Montorsi F.

BJU Int. 2013 Aug;112(4):432-41. doi: 10.1111/bju.12118. Epub 2013 Apr 12. Review.

16.

Convective Water Vapor Energy for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.

DeLay KJ, McVary KT.

Urol Clin North Am. 2016 Aug;43(3):371-5. doi: 10.1016/j.ucl.2016.04.005. Review.

PMID:
27476129
17.

Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.

Fwu CW, Eggers PW, Kirkali Z, McVary KT, Burrows PK, Kusek JW.

J Urol. 2014 Jun;191(6):1828-34. doi: 10.1016/j.juro.2013.12.014. Epub 2013 Dec 14.

PMID:
24342143
18.

Re: The Role of Inflammation in Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) and its Potential Impact on Medical Therapy.

Kaplan SA.

J Urol. 2016 Mar;195(3):689-90. doi: 10.1016/j.juro.2015.12.039. Epub 2015 Dec 14. No abstract available.

PMID:
26887734
19.

Early Experiences of Contact Laser Vaporization of the Prostate using the 980 nm High Power Diode Laser for Benign Prostatic Hyperplasia.

Miyazaki H, Hirano Y, Kato S, Ioritani N, Ichikawa T, Takamoto H, Homma Y.

Low Urin Tract Symptoms. 2018 Sep;10(3):242-246. doi: 10.1111/luts.12173. Epub 2017 Jun 2.

PMID:
28573791
20.

Correlation between benign prostatic hyperplasia and inflammation.

Bostanci Y, Kazzazi A, Momtahen S, Laze J, Djavan B.

Curr Opin Urol. 2013 Jan;23(1):5-10. doi: 10.1097/MOU.0b013e32835abd4a. Review.

PMID:
23159991

Supplemental Content

Support Center